Valuation : RaySearch Laboratories AB

Market Cap 621.25Cr 65Cr 56Cr 52Cr 48Cr 90Cr 6.19TCr 90Cr 242.39Cr 3.13TCr 243.34Cr 238.04Cr 10TCr P/E 2026 *
23.1x
P/E 2027 * 18.5x
Enterprise Value 636.75Cr 66Cr 57Cr 54Cr 49Cr 92Cr 6.35TCr 93Cr 248.44Cr 3.2TCr 249.41Cr 243.98Cr 11TCr EV / Sales 2026 *
4.56x
EV / Sales 2027 * 3.81x
Free-Float
80.09%
Yield 2026 *
2.16%
Yield 2027 * 2.58%
1 day+5.09%
1 week+5.09%
Current month+5.09%
1 month+5.09%
3 months-19.55%
6 months-13.87%
Current year-16.76%
1 week 19.81
Extreme 19.81
19.81
1 month 19.81
Extreme 19.81
19.81
Current year 16.85
Extreme 16.85
24.62
1 year 16.85
Extreme 16.85
27.61
3 years 8
Extreme 8
37.36
5 years 4.04
Extreme 4.039
37.36
10 years 4.04
Extreme 4.039
37.36
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+5.09%+5.09% - - 65Cr
-1.93%+11.61%+1.60%+45.33% 4.48TCr
+1.25%-5.28%-39.51%+147.69% 1.36TCr
+1.55%+3.45%-14.15%+68.09% 578.08Cr
-0.67%-3.96%+48.66% - 415.46Cr
-2.79%-4.90% - - 196.76Cr
-0.99%-7.03%-0.60%-41.79% 150.89Cr
+6.45%-3.07%-30.37% - 114.55Cr
-1.93%-2.69%+38.15%+150.99% 100.31Cr
-3.78%-4.32%+46.85%+57.63% 98Cr
Average +0.23%-1.60%+6.33%+71.32% 832.71Cr
Weighted average by Cap. -0.86%+5.65%-4.07%+67.65%

Financials

2026 *2027 *
Net sales 139.65Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 54Cr 702.88Cr 55Cr 54Cr 2.33TCr 163.15Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.63TCr 24Cr 64Cr 821.16Cr 64Cr 63Cr 2.72TCr
Net income 27Cr 2.84Cr 2.45Cr 2.29Cr 2.09Cr 3.94Cr 271.2Cr 3.96Cr 11Cr 136.9Cr 11Cr 10Cr 453.95Cr 34Cr 3.52Cr 3.03Cr 2.84Cr 2.6Cr 4.89Cr 336.51Cr 4.91Cr 13Cr 169.87Cr 13Cr 13Cr 563.26Cr
Net Debt 16Cr 1.62Cr 1.39Cr 1.31Cr 1.19Cr 2.25Cr 154.55Cr 2.25Cr 6.05Cr 78Cr 6.07Cr 5.94Cr 258.68Cr 70L 7L 6L 6L 5L 10.15L 6.98Cr 10.18L 27.31L 3.52Cr 27.42L 26.82L 12Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
184.80SEK
Average target price
297.50SEK
Spread / Average Target
+60.98%

Quarterly revenue - Rate of surprise